Vivos Therapeutics Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Third Quarter 2022 Quarterly Report On Form 10-Q
Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or the "Company") today announced that it has received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock